New hope for rare blood disorder: gentler transplant trial seeks to save lives
NCT ID NCT02143830
Summary
This study is testing a modified stem cell transplant procedure for patients with Fanconi anemia who have developed severe blood problems like bone marrow failure or leukemia. The goal is to see if using lower doses of certain chemotherapy drugs and removing another medication can reduce dangerous side effects while still allowing the transplant to work. The procedure uses stem cells from a partially matched family member or an unrelated donor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME (MDS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
Contact
-
Fred Hutchinson Cancer Research Center
RECRUITINGSeattle, Washington, 98109, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Memorial Sloan Kettering Cancer Center
COMPLETEDNew York, New York, 10174, United States
Conditions
Explore the condition pages connected to this study.